The Latest Breaking News from Breast Cancer

PHILADELPHIA -- Rutgers researchers made a startling discovery when the pandemic curtailed routine medical visits: Going virtual to test cutting-edge therapies reached more diverse patients.

The FDA has approved AstraZeneca plc (NASDAQ:AZN) and Daiichi Sankyo's (OTC:DSKYF) Enhertu (trastuzumab deruxtecan) for adult patients with unresectable or metastatic HER2-positive breast cancer. The approval covers patients who have received a prior anti-HER2-based regimen either in the metastatic setting or in the neoadjuvant or adjuvant setting and have developed disease recurrence during or within…

Dieticians believe shedding just 7lb can do wonders for your physical health in many ways

Novartis AG (NYSE:NVS) has announced updated median overall survival (OS) results for Kisqali (ribociclib) combined with fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or metastatic breast cancer.  The analysis of patients treated in first-line with Kisqali plus fulvestrant demonstrated a significant OS benefit of nearly…

Here's a roundup of top developments in the biotech space over the last 24 hours.

SAN DIEGO -- On the last Sunday of each month, 89-year-old Pat Anderson of Escondido, California, gets together with the six other local senior women who make up her highly specialized knitting circle. But don't let these ladies' shared passion for knitting fool you into thinking they're leisurely hobbyists.

Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pharma earnings, clinical readouts and pipeline updates moved stocks during the week.

Roisin Pelan has set herself a new mission - educating pregnant women and new mums about breast cancer and getting them to do a few simple regular checks

Malandra Burrows starred in the ITV soap for 16 years